211 related articles for article (PubMed ID: 22136096)
1. Co-morbid disruptive behavior disorder and aggression predict functional outcomes and differential response to risperidone versus divalproex in pharmacotherapy for pediatric bipolar disorder.
West AE; Weinstein SM; Celio CI; Henry D; Pavuluri MN
J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):545-53. PubMed ID: 22136096
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).
Barzman DH; DelBello MP; Adler CM; Stanford KE; Strakowski SM
J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):665-70. PubMed ID: 17201610
[TBL] [Abstract][Full Text] [Related]
3. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study.
Vitiello B; Riddle MA; Yenokyan G; Axelson DA; Wagner KD; Joshi P; Walkup JT; Luby J; Birmaher B; Ryan ND; Emslie G; Robb A; Tillman R
J Am Acad Child Adolesc Psychiatry; 2012 Sep; 51(9):867-78. PubMed ID: 22917200
[TBL] [Abstract][Full Text] [Related]
4. Comorbid anxiety and social avoidance in treatment of severe childhood aggression: response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response.
Arnold LE; Gadow KD; Farmer CA; Findling RL; Bukstein O; Molina BS; Brown NV; Li X; Rundberg-Rivera EV; Bangalore S; Buchan-Page K; Hurt EA; Rice R; McNamara NK; Aman MG
J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):203-12. PubMed ID: 25885010
[TBL] [Abstract][Full Text] [Related]
5. Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder.
Pavuluri MN; Henry DB; Findling RL; Parnes S; Carbray JA; Mohammed T; Janicak PG; Sweeney JA
Bipolar Disord; 2010 Sep; 12(6):593-605. PubMed ID: 20868458
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy.
Blader JC; Schooler NR; Jensen PS; Pliszka SR; Kafantaris V
Am J Psychiatry; 2009 Dec; 166(12):1392-401. PubMed ID: 19884222
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents.
Geller B; Luby JL; Joshi P; Wagner KD; Emslie G; Walkup JT; Axelson DA; Bolhofner K; Robb A; Wolf DV; Riddle MA; Birmaher B; Nusrat N; Ryan ND; Vitiello B; Tillman R; Lavori P
Arch Gen Psychiatry; 2012 May; 69(5):515-28. PubMed ID: 22213771
[TBL] [Abstract][Full Text] [Related]
8. Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder: fMRI outcomes.
Pavuluri MN; Passarotti AM; Lu LH; Carbray JA; Sweeney JA
Psychiatry Res; 2011 Jul; 193(1):28-37. PubMed ID: 21592741
[TBL] [Abstract][Full Text] [Related]
9. The influence of risperidone on attentional functions in children and adolescents with attention-deficit/hyperactivity disorder and co-morbid disruptive behavior disorder.
Günther T; Herpertz-Dahlmann B; Jolles J; Konrad K
J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):725-35. PubMed ID: 17201616
[TBL] [Abstract][Full Text] [Related]
10. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
11. Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder.
MacMillan CM; Withney JE; Korndörfer SR; Tilley CA; Mrakotsky C; Gonzalez-Heydrich JM
J Psychiatr Pract; 2008 May; 14(3):160-9. PubMed ID: 18520785
[TBL] [Abstract][Full Text] [Related]
12. Risperidone and divalproex differentially engage the fronto-striato-temporal circuitry in pediatric mania: a pharmacological functional magnetic resonance imaging study.
Pavuluri MN; Passarotti AM; Fitzgerald JM; Wegbreit E; Sweeney JA
J Am Acad Child Adolesc Psychiatry; 2012 Feb; 51(2):157-170.e5. PubMed ID: 22265362
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy impacts functional connectivity among affective circuits during response inhibition in pediatric mania.
Pavuluri MN; Ellis JA; Wegbreit E; Passarotti AM; Stevens MC
Behav Brain Res; 2012 Jan; 226(2):493-503. PubMed ID: 22004983
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities.
Buitelaar JK; van der Gaag RJ; Cohen-Kettenis P; Melman CT
J Clin Psychiatry; 2001 Apr; 62(4):239-48. PubMed ID: 11379837
[TBL] [Abstract][Full Text] [Related]
15. Placebo-controlled trial of valproic Acid versus risperidone in children 3-7 years of age with bipolar I disorder.
Kowatch RA; Scheffer RE; Monroe E; Delgado S; Altaye M; Lagory D
J Child Adolesc Psychopharmacol; 2015 May; 25(4):306-13. PubMed ID: 25978742
[TBL] [Abstract][Full Text] [Related]
16. Divalproex sodium reduces overall aggression in youth at high risk for bipolar disorder.
Saxena K; Howe M; Simeonova D; Steiner H; Chang K
J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):252-9. PubMed ID: 16768633
[TBL] [Abstract][Full Text] [Related]
17. Child Mania Rating Scale-Parent Version: a valid measure of symptom change due to pharmacotherapy.
West AE; Celio CI; Henry DB; Pavuluri MN
J Affect Disord; 2011 Jan; 128(1-2):112-9. PubMed ID: 20858565
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Early-Age Mania: Outcomes for Partial and Nonresponders to Initial Treatment.
Walkup JT; Wagner KD; Miller L; Yenokyan G; Luby JL; Joshi PT; Axelson DA; Robb A; Salpekar JA; Wolf D; Sanyal A; Birmaher B; Vitiello B; Riddle MA
J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):1008-19. PubMed ID: 26598476
[TBL] [Abstract][Full Text] [Related]
19. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence.
Aman MG; De Smedt G; Derivan A; Lyons B; Findling RL;
Am J Psychiatry; 2002 Aug; 159(8):1337-46. PubMed ID: 12153826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
